Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Pancréas
- Tumeurs endocrines digestives
- | Specialty :
- Chimiothérapie
Extract
Phase III, randomised, double-blind, stratified comparative, placebo controlled, parallel group, multi-centre study to assess the effect of deep subcutaneous injections of lanreotide autogel 120mg administered every 28 days on tumour progression free survival in patients with non-functioning entero-pancreatic endocrine tumour.
Scientific Abstract
en cours d'intégration;